日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distal Fecal Wash Host Transcriptomics Identifies Inflammation Throughout the Colon and Terminal Ileum

远端粪便冲洗液宿主转录组学分析揭示结肠和末端回肠的炎症

Dan, Stav; Ungar, Bella; Ben-Moshe, Shani; Bahar Halpern, Keren; Yavzori, Miri; Fudim, Ella; Picard, Orit; Abitbol, Chaya Mushka; Harnik, Sivan; Barshack, Iris; Kopylov, Uri; Ben-Horin, Shomron; Itzkovitz, Shalev

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

维多珠单抗谷浓度能否预测炎症性肠病后续治疗的效果?

Levartovsky, Asaf; Cohen, Ido; Abitbol, Chaya Mushka; Yavzori, Miri; Fudim, Ella; Picard, Orit; Kopylov, Uri; Ben-Horin, Shomron; Ungar, Bella

Baseline Peripheral Blood Mononuclear Cell Transcriptomics Before Ustekinumab Treatment Is Linked With Crohn's Disease Clinical Response at 1 Year

乌司奴单抗治疗前外周血单核细胞转录组学与克罗恩病1年后的临床反应相关

Granot, Maya; Braun, Tzipi; Efroni, Gilat; Picard, Orit; Fudim, Ella; Yavzori, Miri; Haj, Ola; Weiss, Batia; Ben-Horin, Shomron; Kopylov, Uri; Haberman, Yael

Acute Chest Pain as an Infusion Reaction to Vedolizumab

维多珠单抗输注反应引起的急性胸痛

Levartovsky, Asaf; Yavzori, Miri; Fudim, Ella; Kopylov, Uri; Ben-Horin, Shomron; Ungar, Bella

Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening

延迟3天以上输注英夫利昔单抗会导致谷浓度显著降低,但不会导致临床症状恶化。

Ben-Shatach, Zohar; Ziv-Baran, Tomer; Fudim, Ella; Yavzori, Miri; Picard, Orit; Levartovsky, Asaf; Selinger, Limor; Weiss, Batia; Kopylov, Uri; Eliakim, Rami; Ungar, Bella

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.

血清 MMP-9:一种预测静止期克罗恩病患者临床复发的新型生物标志物——事后分析

Yablecovitch Doron, Kopylov Uri, Lahat Adi, Amitai Michal M, Klang Eyal, Ben-Ami Shor Dana, Neuman Sandra, Levhar Nina, Fudim Ella, Avidan Benjamin, Laish Ido, Selinger Limor, Zingboim-Orbach Noam, Picard Orit, Yavzori Miri, Eliakim Rami, Ben-Horin Shomron

Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure

阿什肯纳兹犹太血统可预防英夫利昔单抗抗体的产生和治疗失败。

Ungar, Bella; Haj-Natour, Ola; Kopylov, Uri; Yavzori, Miri; Fudim, Ella; Picard, Orit; Loebstein, Ronen; Lahat, Adi; Maor, Yaakov; Avidan, Benjamin; Lang, Alon; Weiss, Batia; Chowers, Yehuda; Eliakim, Rami; Ben-Horin, Shomron